Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.17 SEK | +0.63% | +14.86% | +11.23% |
04-30 | Transcript : Medivir AB, Q1 2024 Earnings Call, Apr 30, 2024 | |
04-30 | Medivir AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 10
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 4 | 100.0 % | 8 | 100.0 % | +73.16% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
46.9
%
| - | - | 4 | 46.9 % | - |
Europe, Other
43.3
%
| 4 | 80.8 % | 3 | 43.3 % | -7.16% |
Rest of the World
4.8
%
| 0 | 9.9 % | 0 | 4.8 % | -16.21% |
Sweden
2.5
%
| 0 | 5.0 % | 0 | 2.5 % | -13.12% |
Nordic Region, Other
2.4
%
| 0 | 4.2 % | 0 | 2.4 % | -0.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 53 | 22-01-23 |
Director of Finance/CFO | 50 | 19-08-11 | |
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Pia Baumann
CTO | Chief Tech/Sci/R&D Officer | 58 | 23-02-19 |
Malene Jensen
CTO | Chief Tech/Sci/R&D Officer | 54 | 21-09-30 |
Fredrik Öberg
CTO | Chief Tech/Sci/R&D Officer | 59 | 10-12-31 |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 20-05-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Director/Board Member | 68 | 18-05-02 | |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 20-05-25 |
Bengt Westermark
BRD | Director/Board Member | 79 | 17-05-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 864,750 | 0 | 864,750 ( 100.00 %) | 68.69 % |
Stock B | 1 | 104,506,048 | 72,375,356 ( 69.25 %) | 11,413 ( 0.0109 %) |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.23% | 32.17M | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- MVIR B Stock
- Company Medivir AB